Interim proposal for collecting and handling of microbiology specimens from patients with COVID‐19 in general hospitals

Zhaofang Jiang; Shan Chen; Jiayao Qu; Siyuan Liu; Tao Hong; Houming Liu; Yi‐Wei Tang; Jiuxin Qu; Hongzhou Lu

doi:10.1002/ila2.13

iLABMED 2023, 1(1): 15-21 https://doi.org/10.1002/ila2.13

Commentary |

Open Access | Issue | Published: 29 May 2023

Interim proposal for collecting and handling of microbiology specimens from patients with COVID‐19 in general hospitals

Show Author's Information Hide Author's Information Zhaofang Jiang^{¹^,}, Shan Chen^{¹^,}, Jiayao Qu^¹, Siyuan Liu^², Tao Hong^³, Houming Liu^¹, Yi‐Wei Tang^², Jiuxin Qu^¹(

), Hongzhou Lu^¹(

)

Department of Clinical Laboratory, Shenzhen Third People's Hospital, Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases, Shenzhen, Guangdong, China

Department of Medical Affairs, Danaher/Cepheid China, Shanghai, China

Department of Pathology, Rhode Island Hospital, Providence, Rhode Island, USA

Zhaofang Jiang and Shan Chen contributed equally to this work.

Keywords:

biosafety, COVID‐19, microbiology specimens, SARS‐CoV‐2

Cite this article:

Jiang Z, Chen S, Qu J, et al. Interim proposal for collecting and handling of microbiology specimens from patients with COVID‐19 in general hospitals. iLABMED, 2023, 1(1): 15-21. https://doi.org/10.1002/ila2.13

Download citation

EndNote(RIS)

BibTeX

444

Views

Downloads

Citations

Crossref

N/A

WoS

N/A

Scopus

N/A

CSCD

Abstract Full text About this article

Abstract

Full text

Abstract

Full text

Outline

About this article

Interim proposal for collecting and handling of microbiology specimens from patients with COVID‐19 in general hospitals

Show Author's information Hide Author's Information Zhaofang Jiang^{¹^,}, Shan Chen^{¹^,}, Jiayao Qu^¹, Siyuan Liu^², Tao Hong^³, Houming Liu^¹, Yi‐Wei Tang^², Jiuxin Qu^¹(

), Hongzhou Lu^¹(

)

Department of Medical Affairs, Danaher/Cepheid China, Shanghai, China

Department of Pathology, Rhode Island Hospital, Providence, Rhode Island, USA

Zhaofang Jiang and Shan Chen contributed equally to this work.

Keywords: biosafety, COVID‐19, microbiology specimens, SARS‐CoV‐2

References(19)

[1]

Mohsin M, Mahmud S. Omicron SARS‐CoV‐2 variant of concern: a review on its transmissibility, immune evasion, reinfection, and severity. Medicine (Baltim). 2022;101(19): e29165. https://doi.org/10.1097/MD.0000000000029165

DOI Google Scholar

[2]

Landis BC, Brooks AE, Digre KB, Seay MD. Coronavirus disease 2019, eye pain, headache, and beyond. J Neuro Ophthalmol. 2022;42(1): 18–25. https://doi.org/10.1097/WNO.0000000000001526

DOI Google Scholar

[3]

Tian D, Sun Y, Xu H, Ye Q. The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant. J Med Virol. 2022;94(6): 2376–83. https://doi.org/10.1002/jmv.27643

DOI Google Scholar

[4]

Callaway E. Heavily mutated Omicron variant puts scientists on alert. Nature. 2021;600(7887): 21. https://doi.org/10.1038/d41586‐021‐03552‐w

DOI Google Scholar

[5]

CDC. COVID data tracker. Centers for Disease Control and Prevention; 2020. https://covid.cdc.gov/covid‐data‐tracker/#datatracker‐home. Accessed 13 January 2022.

[6]

Collie S, Champion J, Moultrie H, Bekker LG, Gray G. Effectiveness of BNT162b2 vaccine against Omicron variant in South Africa. N Engl J Med. 2022;386(5): 494–6. https://doi.org/10.1056/NEJMc2119270

DOI Google Scholar

[7]

Jung C, Kmiec D, Koepke L, Zech F, Jacob T, Sparrer KMJ, et al. Omicron: What makes the latest SARS‐CoV‐2 variant of concern so concerning? J Virol. 2022;96(6): e0207721. https://doi.org/10.1128/jvi.02077‐21

DOI Google Scholar

[8]

Guo Y, Han J, Zhang Y, He J, Yu W, Zhang X, et al. SARS‐CoV‐2 Omicron variant: epidemiological features, biological characteristics, and clinical significance. Front Immunol. 2022;13: 877101. https://doi.org/10.3389/fimmu.2022.877101

DOI Google Scholar

[9]

Xu A, Hong B, Lou F, Wang S, Li W, Shafqat A, et al. Sub‐lineages of the SARS‐CoV‐2 Omicron variants: characteristics and prevention. MedComm. 2022;3(3): e172. https://doi.org/10.1002/mco2.172

DOI Google Scholar

[10]

Kupferschmidt K, Vogel G. Omicron threat remains fuzzy as cases explode. Science. 2022;375(6576): 9–10. https://doi.org/10.1126/science.acz9928

DOI Google Scholar

[11]

Markovskaya Y, Gavioli EM, Cusumano JA, Glatt AE. Coronavirus disease 2019 (COVID‐19): secondary bacterial infections and the impact on antimicrobial resistance during the COVID‐19 pandemic. Antimicrob Steward Healthc Epidemiol. 2022;2(1): e114. https://doi.org/10.1017/ash.2022.253

DOI Google Scholar

[12]

Hoenigl M, Seidel D, Sprute R, Cunha C, Oliverio M, Goldman GH, et al. COVID‐19‐associated fungal infections. Nat Microbiol. 2022;7(8): 1127–40. https://doi.org/10.1038/s41564‐022‐01172‐2

DOI Google Scholar

[13]

Mina S, Yaakoub H, Annweiler C, Dubée V, Papon N. COVID‐19 and Fungal infections: a double debacle. Microb Infect. 2022;24(8): 105039. https://doi.org/10.1016/j.micinf.2022.105039

DOI Google Scholar

[14]

National Health Commission of the People’s Republic of China. Technical guidelines for specimen collection and detection of SARS‐CoV‐2[S]; 2022. http://www.nhc.gov.cn

[15]

pecimens for COVID‐19 Testing[EB/OL]. https://www.cdc. gov/coronavirus/2019‐ncov/lab/guidelines‐clinical‐specimens.html

[16]

Dinnes J, Sharma P, Berhane S, van Wyk SS, Nyaaba N, Domen J, et al. Cochrane COVID‐19 Diagnostic Test Accuracy Group. Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection. Cochrane Database Syst Rev. 2022;7(7):CD013705. https://doi.org/10.1002/14651858.CD013705.pub3

DOI Google Scholar

[17]

Meng Z, Guo S, Zhou Y, Li M, Wang M, Ying B. Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID‐19. Signal Transduct Targeted Ther. 2021;6(1):316. https://doi.org/10.1038/s41392‐021‐00731‐z

DOI Google Scholar

[18]

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. China medical treatment expert group for covid‐19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. https://doi.org/10.1056/NEJMoa2002032

DOI Google Scholar

[19]

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID‐19): a review. JAMA. 2020;324(8):782–93. https://doi.org/10.1001/jama.2020.12839

DOI Google Scholar

About this article

Publication history

Acknowledgements

Rights and permissions

Publication history

Published: 29 May 2023

Issue date: June 2023

Copyright

Acknowledgements

ACKNOWLEDGMENTS

None.

Rights and permissions

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.